ClinicalTrials.Veeva

Menu

Intravenous Versus Intra-peritoneal Dexamethasone on the Incidence of Postoperative Nausea and Vomiting

A

Assiut University

Status

Completed

Conditions

Postoperative Nausea and Vomiting

Treatments

Drug: Intravenous Dexamethasone
Drug: Intraperitoneal Dexamesathone

Study type

Interventional

Funder types

Other

Identifiers

NCT02947672
01003060377

Details and patient eligibility

About

Effect of intravenous versus intra-peritoneal dexamethasone on the incidence of postoperative nausea and vomiting following Laparoscopic gynecological surgeries.

Enrollment

100 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adult Female patients
  2. American society of anesthesiologist class I & II
  3. Undergoing Laparoscopic gynecological surgeries

Exclusion criteria

  1. Patient refusal to participate in the study
  2. Patients with coagulopathy or under anticoagulation therapy.
  3. Infection near the site of needle insertion.
  4. Body mass index > 40kg/m2
  5. Patients with any neurological or neuromuscular disorder or history of seizures.
  6. Known allergy to any drug used in the study.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

100 participants in 2 patient groups

Intravenous dexamethasone
Active Comparator group
Description:
50 patients will receive intravenous dexamethasone
Treatment:
Drug: Intravenous Dexamethasone
Intra peritoneal dexamethasone
Active Comparator group
Description:
50 patients will receive intraperitoneal dexamethasone
Treatment:
Drug: Intraperitoneal Dexamesathone

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems